Maxion Therapeutics is a UK biotechnology company developing protein therapeutics using its proprietary KnotBody technology, which fuses venom-derived knottin miniproteins with antibodies to drug previously untreatable ion channel- and GPCR-driven diseases across autoimmune, inflammatory, and related therapeutic areas. - View it on GitHub